Beckman Coulter to Acquire Lumigen
- Share via
From Bloomberg News
Beckman Coulter Inc. said it would buy Lumigen Inc., a maker of chemicals used in diagnostics and scientific research, for $185 million in cash.
The transaction is expected to have no effect on Beckman Coulter’s financial results this year and to add at least 2 cents a share to earnings next year, the Fullerton company said.
The laboratory equipment maker accounted for 40% of Southfield, Mich.-based Lumigen’s $33 million in revenue last year, the companies said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
